A detailed history of Canada Pension Plan Investment Board transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 50,700 shares of EYPT stock, worth $317,889. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,700
Previous 24,000 111.25%
Holding current value
$317,889
Previous $191,000 97.38%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$7.02 - $12.12 $187,434 - $323,604
26,700 Added 111.25%
50,700 $377,000
Q3 2024

Nov 14, 2024

BUY
$7.58 - $10.54 $63,672 - $88,536
8,400 Added 53.85%
24,000 $191,000
Q2 2024

Aug 12, 2024

SELL
$8.16 - $22.89 $933,504 - $2.62 Million
-114,400 Reduced 88.0%
15,600 $135,000
Q1 2024

May 14, 2024

BUY
$19.93 - $29.71 $2.59 Million - $3.86 Million
130,000 New
130,000 $2.69 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $214M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.